BA1 - Rewriting Autoimmunity: New Immunologic Insights Transforming T1D Therapy Development, Sponsored by Breakthrough T1D

Thursday, April 16, 2026

7:00 AM - 8:00 AM US ET

Location: 151

Sponsored By

Chair(s)

GG

Gregory Golden, Ph.D.

Scientist
Breakthrough T1D
Joshua Vieth, PhD

Senior Director of Research
Breakthrough T1D

Speaker(s)

Elly M. Puckett (she/her/hers)

PhD Candidate
University of Kansas Medical Center
Kansas City, Kansas, United States
Tyler W. Jenkins, PhD

Postdoctoral Research Trainee
Vanderbilt Univ. Med. Ctr., United States
Jacquelyn Nestor, MD, PhD

Instructor
Massachusetts Gen. Hosp., Harvard Med. Sch.
Boston, Massachusetts, United States
Erin Maule (she/her/hers)

PhD Candidate
University of Pennsylvania Perelman School of Medicine
Philadelphia, Pennsylvania, United States

Disclosure(s):

Joshua Vieth, PhD: No financial relationships to disclose

Elly M. Puckett: No financial relationships to disclose

Erin Maule: No financial relationships to disclose

BreakthoughT1D has organized and sponsored a satellite symposium, "Rewriting Autoimmunity: New Immunologic Insights Transforming T1D Therapy Development." This symposium will highlight how emerging insights are reshaping our understanding of type 1 diabetes (T1D) pathogenesis and therapeutic opportunities. Speakers will discuss how recent research advances are positioning T1D as both a proving ground for targeted immune intervention and a model for organ-specific autoimmunity more broadly.